Published in Biochem J on June 01, 1977
Pathogenesis of the adult respiratory distress syndrome. Evidence of oxidant activity in bronchoalveolar lavage fluid. J Clin Invest (1983) 2.37
Protease and elastase of Pseudomonas aeruginosa: inactivation of human plasma alpha 1-proteinase inhibitor. Infect Immun (1979) 2.08
Potential mechanism of emphysema: alpha 1-proteinase inhibitor recovered from lungs of cigarette smokers contains oxidized methionine and has decreased elastase inhibitory capacity. Proc Natl Acad Sci U S A (1982) 1.99
Limited proteolysis by macrophage elastase inactivates human alpha 1-proteinase inhibitor. J Exp Med (1980) 1.38
Human cystatin C. role of the N-terminal segment in the inhibition of human cysteine proteinases and in its inactivation by leucocyte elastase. Biochem J (1991) 1.22
Oxidative regulation of neutrophil elastase-alpha-1-proteinase inhibitor interactions. J Clin Invest (1986) 1.22
Roles for proteinases in the pathogenesis of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2008) 1.18
Regulation of alpha 1 proteinase inhibitor function by rabbit alveolar macrophages. Evidence for proteolytic rather than oxidative inactivation. J Clin Invest (1985) 1.00
The structural basis for neutrophil inactivation of C1 inhibitor. Biochem J (1989) 0.99
Interaction of mouse macrophage elastase with native and oxidized human alpha 1-proteinase inhibitor. J Clin Invest (1987) 0.94
Experimental pulmonary inflammatory injury in the monkey. J Clin Invest (1985) 0.91
Cleavage and inactivation of alpha 1-antitrypsin by metalloproteinases released from neutrophils. J Clin Invest (1988) 0.88
Structural comparisons of the native and reactive-centre-cleaved forms of alpha 1-antitrypsin by neutron- and X-ray-scattering in solution. Biochem J (1990) 0.87
Inhibitory capacity of alpha 1 antitrypsin in lung secretions: variability and the effect of drugs. Thorax (1984) 0.83
E64 [trans-epoxysuccinyl-L-leucylamido-(4-guanidino)butane] analogues as inhibitors of cysteine proteinases: investigation of S2 subsite interactions. Biochem J (1994) 0.81
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
A protein sequenator. Eur J Biochem (1967) 17.03
A spectrophotometric determination of trypsin and chymotrypsin. Biochim Biophys Acta (1955) 7.79
The application of 0.1 M quadrol to the microsequence of proteins and the sequence of tryptic peptides. Biochemistry (1975) 5.31
Human cathepsin B1. Purification and some properties of the enzyme. Biochem J (1973) 4.06
Human leukocyte granule elastase: rapid isolation and characterization. Biochemistry (1976) 3.57
Regeneration of amino acids from thiazolinones formed in the Edman degradation. Anal Biochem (1975) 2.86
Isolation and properties of human plasma alpha-1-proteinase inhibitor. Biochemistry (1974) 2.40
Inhibition by alpha-macroglobulin and other serum proteins. Biochem J (1973) 1.40
ENZYMATICALLY PRODUCED PULMONARY EMPHYSEMA; A PRELIMINARY REPORT. J Occup Med (1964) 1.32
On the production of emphysema in Syrian hamsters by aerosol inhalation of papain. Arch Environ Health (1968) 1.05
Human alpha-1-proteinase inhibitor mechanism of action: evidence for activation by limited proteolysis. Biochem Biophys Res Commun (1976) 0.98
Effect of human alpha-antitrypsin in papain-induced emphysema in the hamster. Am Rev Respir Dis (1976) 0.97
Gene expression analysis by massively parallel signature sequencing (MPSS) on microbead arrays. Nat Biotechnol (2000) 15.79
The genome of the social amoeba Dictyostelium discoideum. Nature (2005) 9.18
Standardisation of the measurement of lung volumes. Eur Respir J (2005) 7.48
The DNA sequence and comparative analysis of human chromosome 20. Nature (2002) 7.40
Human plasma proteinase inhibitors. Annu Rev Biochem (1983) 6.61
Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer. N Engl J Med (1991) 6.33
Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients. Nat Med (1999) 6.09
Herpes simplex virus turns off the TAP to evade host immunity. Nature (1995) 5.93
Climate impact of increasing atmospheric carbon dioxide. Science (1981) 5.67
Sequence and analysis of chromosome 4 of the plant Arabidopsis thaliana. Nature (1999) 5.03
The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature. J Biol Chem (2001) 4.81
Expression and structure of the human NGF receptor. Cell (1986) 3.82
The stroke impact scale version 2.0. Evaluation of reliability, validity, and sensitivity to change. Stroke (1999) 3.76
Human leukocyte granule elastase: rapid isolation and characterization. Biochemistry (1976) 3.57
Kinetics of association of serine proteinases with native and oxidized alpha-1-proteinase inhibitor and alpha-1-antichymotrypsin. J Biol Chem (1980) 3.14
emm typing and validation of provisional M types for group A streptococci. Emerg Infect Dis (1999) 3.12
The serpin superfamily of proteinase inhibitors: structure, function, and regulation. J Biol Chem (1994) 3.07
Prognostic value of tumor "budding" in patients with colorectal cancer. Dis Colon Rectum (1993) 2.92
Lysine- and arginine-specific proteinases from Porphyromonas gingivalis. Isolation, characterization, and evidence for the existence of complexes with hemagglutinins. J Biol Chem (1994) 2.90
Abnormal noradrenergic function in posttraumatic stress disorder. Arch Gen Psychiatry (1993) 2.89
Using social network and ethnographic tools to evaluate syphilis transmission. Sex Transm Dis (1998) 2.81
Career and parenting satisfaction among medical students, residents and physician teachers at a Canadian medical school. CMAJ (2000) 2.81
Selective removal of albumin from plasma by affinity chromatography. Clin Chim Acta (1973) 2.69
Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer. J Natl Cancer Inst (1995) 2.64
Sequence of Plasmodium falciparum chromosomes 1, 3-9 and 13. Nature (2002) 2.59
The oxidative inactivation of human alpha-1-proteinase inhibitor. Further evidence for methionine at the reactive center. J Biol Chem (1979) 2.57
Sequence interpretation. Functional annotation of mouse genome sequences. Science (2001) 2.54
A deubiquitinating enzyme interacts with SIR4 and regulates silencing in S. cerevisiae. Cell (1996) 2.47
Primary structure of human neutrophil elastase. Proc Natl Acad Sci U S A (1987) 2.45
The DNA sequence and biological annotation of human chromosome 1. Nature (2006) 2.42
Isolation and properties of human plasma alpha-1-proteinase inhibitor. Biochemistry (1974) 2.40
Vibration and praise as reinforcers for mentally handicapped people. Ment Retard (1978) 2.38
Role of bacterial proteinases in matrix destruction and modulation of host responses. Periodontol 2000 (2000) 2.29
A theoretical investigation of reference frames for the planning of speech movements. Psychol Rev (1998) 2.24
Molecular cloning of human cathepsin G: structural similarity to mast cell and cytotoxic T lymphocyte proteinases. Biochemistry (1987) 2.24
Multicenter evaluation of the Cepheid Xpert methicillin-resistant Staphylococcus aureus (MRSA) test as a rapid screening method for detection of MRSA in nares. J Clin Microbiol (2009) 2.20
Structured exercise improves physical functioning in women with stages I and II breast cancer: results of a randomized controlled trial. J Clin Oncol (2001) 2.16
Sequence and analysis of chromosome 5 of the plant Arabidopsis thaliana. Nature (2000) 2.16
Isolation of albumin from whole human plasma and fractionation of albumin-depleted plasma. Biochem J (1976) 2.15
Gene structure and properties of TIGR, an olfactomedin-related glycoprotein cloned from glucocorticoid-induced trabecular meshwork cells. J Biol Chem (1998) 2.13
Unsuspected infectious diseases and other medical diagnoses in the evaluation of internationally adopted children. Pediatrics (1989) 2.12
Invasive group A streptococcal infections in North Carolina: epidemiology, clinical features, and genetic and serotype analysis of causative organisms. J Infect Dis (1997) 2.09
Nosocomial infections due to Pseudomonas aeruginosa: review of recent trends. Rev Infect Dis (1984) 2.08
Rapid detection of Staphylococcus aureus and methicillin-resistant S. aureus (MRSA) in wound specimens and blood cultures: multicenter preclinical evaluation of the Cepheid Xpert MRSA/SA skin and soft tissue and blood culture assays. J Clin Microbiol (2009) 2.07
The multiple forms of trypsin-like activity present in various strains of Porphyromonas gingivalis are due to the presence of either Arg-gingipain or Lys-gingipain. Infect Immun (1995) 2.03
Social network methods for endemic foci of syphilis: a pilot project. Sex Transm Dis (2000) 2.00
Enzymatic inactivation of human alpha-1-proteinase inhibitor by neutrophil myeloperoxidase. Biochem Biophys Res Commun (1979) 2.00
High-risk behaviors during incarceration in African-American men treated for HIV at three Los Angeles public medical centers. J Acquir Immune Defic Syndr (2000) 2.00
Statistical invalidation of the Hubble law. Proc Natl Acad Sci U S A (1980) 1.99
Purification and characterization of a 50-kDa cysteine proteinase (gingipain) from Porphyromonas gingivalis. J Biol Chem (1992) 1.99
A new method of DNA denaturation mapping. Nucleic Acids Res (1975) 1.99
Cellular pharmacology and molecular biology of the trabecular meshwork inducible glucocorticoid response gene product. Ophthalmologica (1997) 1.98
Molecular cloning and structural characterization of the Arg-gingipain proteinase of Porphyromonas gingivalis. Biosynthesis as a proteinase-adhesin polyprotein. J Biol Chem (1995) 1.98
Proteinase-mediated insect resistance to Bacillus thuringiensis toxins. J Biol Chem (1997) 1.98
Activation of complement components C3 and C5 by a cysteine proteinase (gingipain-1) from Porphyromonas (Bacteroides) gingivalis. J Biol Chem (1992) 1.96
Purification, characterization, and sequence analysis of a potential virulence factor from Porphyromonas gingivalis, peptidylarginine deiminase. Infect Immun (1999) 1.96
Anisometropia and binocularity. Ophthalmology (1996) 1.87
Why Eric Mazur Brings Chaos--Not Chaos Theory--to Physics. Science (1994) 1.87
Paternal origin of FGFR2 mutations in sporadic cases of Crouzon syndrome and Pfeiffer syndrome. Am J Hum Genet (2000) 1.85
Evaluation of the Hybrid Capture human papillomavirus deoxyribonucleic acid detection test. Am J Obstet Gynecol (1995) 1.80
Structural evidence for methionine at the reactive site of human alpha-1-proteinase inhibitor. J Biol Chem (1978) 1.79
Crystal structure of gingipain R: an Arg-specific bacterial cysteine proteinase with a caspase-like fold. EMBO J (1999) 1.79
Does primary intraocular lens implantation prevent "aphakic" glaucoma in children? J AAPOS (2000) 1.77
Adipsin: a circulating serine protease homolog secreted by adipose tissue and sciatic nerve. Science (1987) 1.77
Activation of protease-activated receptors by gingipains from Porphyromonas gingivalis leads to platelet aggregation: a new trait in microbial pathogenicity. Blood (2001) 1.77
X-ray crystal structure of the complex of human leukocyte elastase (PMN elastase) and the third domain of the turkey ovomucoid inhibitor. EMBO J (1986) 1.76
Re-engineering adenovirus regulatory pathways to enhance oncolytic specificity and efficacy. Nat Biotechnol (2001) 1.74
Isolation and properties of human neutrophil myeloperoxidase. Biochemistry (1981) 1.71
Characterization of the binding activities of proteinase-adhesin complexes from Porphyromonas gingivalis. J Bacteriol (1996) 1.69
Comparative properties of two cysteine proteinases (gingipains R), the products of two related but individual genes of Porphyromonas gingivalis. J Biol Chem (1998) 1.68
Antibiotic-associated pseudomembranous enteritis due to Clostridium difficile. Clin Infect Dis (1994) 1.68
Reviving the antibiotic miracle? Science (1994) 1.67
Pacemaker patient-triggered event recording: accuracy, utility, and cost for the pacemaker follow-up clinic. Pacing Clin Electrophysiol (1996) 1.60
Phase II study of taxol, merbarone, and piroxantrone in stage IV non-small-cell lung cancer: The Eastern Cooperative Oncology Group Results. J Natl Cancer Inst (1993) 1.59
Pathogenesis of periodontitis: a major arginine-specific cysteine proteinase from Porphyromonas gingivalis induces vascular permeability enhancement through activation of the kallikrein/kinin pathway. J Clin Invest (1994) 1.56
Isolation and properties of oxidized alpha-1-proteinase inhibitor from human rheumatoid synovial fluid. Biochem Biophys Res Commun (1980) 1.56
The Drosophila Hrb87F gene encodes a new member of the A and B hnRNP protein group. Nucleic Acids Res (1991) 1.55
Cyclic chemotherapy with cyclophosphamide, doxorubicin, and cisplatin plus vinblastine and bleomycin in advanced germinal tumors. Results with 100 patients. Am J Med (1986) 1.55
Positive end-expiratory pressure increases the right-to-left shunt in mechanically ventilated patients with patent foramen ovale. Ann Intern Med (1993) 1.55
Cardiac surgery increases the activity of matrix metalloproteinases and nitric oxide synthase in human hearts. J Thorac Cardiovasc Surg (2001) 1.55
Inhibition of Neisseria gonorrhoeae by a bacteriocin from Pseudomonas aeruginosa. Antimicrob Agents Chemother (1976) 1.52
Rapid conversion of angiotensin I to angiotensin II by neutrophil and mast cell proteinases. J Biol Chem (1982) 1.51
Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: final results of an intergroup trial. The Eastern Cooperative Oncology Group, Southwest Oncology Group, and Southeastern Cancer Study Group. J Clin Oncol (1994) 1.51
Oncology Rehabilitation Program at the Ottawa Regional Cancer Centre: program description. CMAJ (1999) 1.51
Unique structures formed by pyrimidine-purine DNAs which may be four-stranded. Proc Natl Acad Sci U S A (1978) 1.50
De novo alu-element insertions in FGFR2 identify a distinct pathological basis for Apert syndrome. Am J Hum Genet (1999) 1.50
Strong constraints on the rare decays B(s)(0) → μ+ μ- and B0 → μ+ μ-. Phys Rev Lett (2012) 1.50
First observation of the decays B(0) → D(+)K(-)π(+)π(-) and B(-) → D(0)K(-)π(+)π(-). Phys Rev Lett (2012) 1.50
Red blood cell mean corpuscular volume: a potential indicator of alcohol usage in a working population. Am J Med Sci (1974) 1.49
Titration and mapping of the active site of cysteine proteinases from Porphyromonas gingivalis (gingipains) using peptidyl chloromethanes. Biol Chem (1997) 1.48
Recent corticosteroid use and the risk of complicated varicella in otherwise immunocompetent children. Arch Pediatr Adolesc Med (1996) 1.47
Effect of severity of meningitis on fungicidal activity of flucytosine combined with fluconazole in a murine model of cryptococcal meningitis. Antimicrob Agents Chemother (1997) 1.46